Clinical trials
Communication Disorders trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2014 | 2 |
| 2016 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 4 |
| 2022 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 5 |
| Terminated | 3 |
| Recruiting | 2 |
| Unknown status | 2 |
| Not yet recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Assistance Publique - Hôpitaux de Paris | 2 |
| University Hospital, Montpellier | 2 |
| University Hospital, Toulouse | 2 |
| Central Hospital, Nancy, France | 1 |
| Centre Hospitalier Universitaire de Besancon | 1 |
| Centre Hospitalier Universitaire de Nice | 1 |
| Hospices Civils de Lyon | 1 |
| Institut Cancerologie de l'Ouest | 1 |
| Lille Catholic University | 1 |
| University Hospital, Clermont-Ferrand | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Communication Disorders | 14 |
| Anomia | 2 |
| Deglutition Disorders | 2 |
| Aphasia | 1 |
| Aphasia, Primary Progressive | 1 |
| Brain Injuries | 1 |
| Communicable Diseases | 1 |
| Consciousness Disorders | 1 |
| Deafness | 1 |
| Dyslexia | 1 |
Trials
Showing 26 to 14 of 14. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.